These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7941871)

  • 1. [The immunological efficacy of Francisella tularensis outer membranes for hamadryas baboons].
    Khlebnikov VS; Golovlev IR; Zhemchugov VE; Chugunov AM; Averin SF; Afanas'ev SS; Kalachev IIa; Pchelintsev SIu; Kislichkin NN
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):61-4. PubMed ID: 7941871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The opsonizing activity of the sera of hamadryas baboons immunized with a preparation of the outer membranes of Francisella tularensis (based on data from the luminol-dependent luminescence method)].
    Komarov AM; Iurov SV; Pchelintsev SIu; Khlebnikov VS; Arshinov AM; Vorob'ev AA; Afanas'ev SS; Urakov NN
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Apr; (4):47-51. PubMed ID: 1496878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The protective properties of the outer membranes of Francisella tularensis in an experimental infection in guinea pigs].
    Khlebnikov VS; Golovlev IR; Chugunov AM; Zhemchugov VE; Averin SF; Afanas'ev SS; Pshirkov SIu; Konovalov SI; Stepanov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):84-8. PubMed ID: 8184621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence difference between the prototypic Schu S4 strain (A1a) and Francisella tularensis A1a, A1b, A2 and type B strains in a murine model of infection.
    Molins CR; Delorey MJ; Yockey BM; Young JW; Belisle JT; Schriefer ME; Petersen JM
    BMC Infect Dis; 2014 Feb; 14():67. PubMed ID: 24502661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence.
    Fulop M; Manchee R; Titball R
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):245-7. PubMed ID: 8861037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membranes of a lipopolysaccharide-protein complex (LPS-17 kDa protein) as chemical tularemia vaccines.
    Khlebnikov VS; Golovliov IR; Kulevatsky DP; Tokhtamysheva NV; Averin SF; Zhemchugov VE; Pchelintsev SY; Afanasiev SS; Shcherbakov GY
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):227-33. PubMed ID: 8861034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of the antibody response of animals immunized with components of the surface structures of Francisella tularensis].
    Iurov SV; Pchelintsev SIu; Afanas'ev SS; Vorob'ev AA; Urakov NN; Cherenkova GV; Denisova NB; Fedortsov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):54-8. PubMed ID: 1950288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of recombinant tumor necrosis factor on antibody formation in mice immunized with a preparation of the outer membranes from Francisella tularensis].
    Iurov SV; Pchelintsev SIu; Denisov LA; Afanas'eva SS; Uraeva VI; Denisova NB; Cherenkova GV; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):64-7. PubMed ID: 7653140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
    Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
    Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia.
    Fulop M; Manchee R; Titball R
    Vaccine; 1995 Sep; 13(13):1220-5. PubMed ID: 8578807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
    Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.